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Conclusions: Apelin treatment prevents Ang II-mediated hippocampal inﬂammation
and oxidant injury in the hypertensive mice through activation of the BDNF/eNOS/
NO signaling pathway, implicating beneﬁcial effects of the Apelin-APJ system on
the brain of hypertensive mice. Apelin may represent a potential candidate to treat
cardiovascular and cerebrovascular diseases.
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Enhanced inhibitory effects of amiodarone on hERG channels due to a mutation
A561V linked to long QT syndrome type 2
Li Guoliang, Sun Chaofeng
Department of Cardiovascular Medicine, the First Afﬁliated Hospital of Xi’an
Jiaotong University College of Medicine
Objectives: This study was to determine the potential of A561V on the response of
hERG channels to amiodarone and the mechanisms underlying the amiodarone-
induced long QT syndrome.
Methods: A561V-hERG plasmids were transfected into the HEK293 cells stably
expressing WT-hERG channels to mimic heterozygous mutant (WT+A561V-hERG).
Whole-cell patch clamp was used to evaluate electrophysiological consequences.
Laser confocal scanning microscopy was used to evaluate the membrane distribution
of hERG channel protein using a green ﬂuorescent protein tagged to the N-terminus
of hERG.
Results: In comparison of WT-hERG channels exposed to amiodarone, heterozygous
A561V-hERG channels showed signiﬁcant decrease in the maximal density of tail
currents in the presence of amidarone. The maximal density of tail currents was
52.76.65 pA/pF and 29.53.29 pA/pF for WT-hERG, 15.792.58 pA/pF and
9.271.43 pA/pF for heterozygous A561V-hERG, under control condition and
exposed to amiodarone, respectively Additionally, A561V-hERG also altered the
potential of amiodarone on the gating properties of hERG channels, including
activation, steady-state inactivation, recovery from inactivation and deactivation.
Images of amiodarone-treated cells expressing heterozygousA561V-hERG showed a
severe retention of protein in the endoplasmic reticulum and signiﬁcant reduction of
protein expression on the membrane in HEK293 cells, compared to the counterparts of
WT-hERG.
Conclusions: Amiodarone exerts a powerful inhibitory effect on the heterozygous
A561V-hERG channels, suggesting the additive suppression of WT-hERG currents by
A561V-hERG and amiodarone. This may explain the increased risk of drug-induced
LQTS and its propensity to severe arrhythmias in congenital LQT2 individuals
receiving amiodarone.
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Rosiglitazone decreases acute hyperglycemia through restoration of hepatic
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Objectives: Stress hyperglycemia is a common pathological feature during the early
phase after acute myocardial infarction (AMI). Despite this, it is not clear whether the
insulin signaling cascades are perturbed after AMI. It is also unknown whether the
impairment of insulin signaling is etiological for hyperglycemia.
In this study, we evaluate 1) the alteration of insulin signaling cascades in major
insulin responsive tissues in a rat AMI model, 2) the role of insulin sensitizer
rosiglitazone (Ros) in potentiating insulin signaling and reducing hyperglycemia
after AMI.
Methods: The left anterior descending coronary artery of male rats was ligated in the
MI group. Rosiglitazone (4mg/kg) was administrated in rats 5min before ligation in
the MI+Ros group. After 30 minutes of ligation, rats were injected with insulin or PBS
intraperitoneally and sacriﬁced 5 minutes later. Plasma glucose and insulin levels were
measured. Expression and/or phosphorylation of insulin receptor b subunit (IRb),
insulin receptor substrate1 (IRS1), IRS2, IRSs-associated p85 subunit of PI3K and
Akt in liver, skeletal muscle and heart tissues were determined.
Results: Successful MI was conﬁrmed by increased CK-MB release and enlarged
myocardial infract aera by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining. The
plasma glucose levels in MI rats was signiﬁcantly elevated at 5min of ligation
(P<0.01) and increased gradually with the concentration reached 3.4 times than that of
sham controls at 30min. Similarly, rapid increase of insulin concentration in MI
groups was observed. Ros administration signiﬁcantly decreased glucose and insulin
levels in AMI rats.
Although the expression of IRb and IRS1 was comparable in liver tissue in MI and
control rats, insulin-stimulated tyrosine phosphorylation of IR and IRS1 were
signiﬁcantly reduced in MI rats. Similarly, the downstream key molecules such as the
attachment of PI3K p85 subunit to IRS1 was signiﬁcantly impaired, together with the
phosphorylation of Akt on ser473 in MI rats compared with control rats. By contrast,
the expression and phospharylation levels of IRS2, and IRS2-associated p85 in liver
were not signiﬁcantly different among all groups of rats. Ros treatment markedly
improved insulin-stimulated phosphorylation of IRb, IRS1 and Akt in liver tissue
of MI rats.
No signiﬁcant differences were observed for the phosphorylation levels of IRb,
IRS1 and Akt in skeletal muscle or heart among MI and control rats.
Conclusions: Insulin signaling cascades were impaired in liver of rats after AMI. Ros
could potentiate insulin signaling in liver tissue and alleviate systemic metabolicJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bdisorders, suggesting impairment of insulin signaling promote hyperglycemia in the
setting of AMI.
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The Myocardial Protection Effects of STV-1Na on Rats with Myocardial
Infarction
Luo Yanting, Liu Jinlai
Department of Cardiology, The Third Afﬁliated Hospital, Sun Yat-sen University
Objectives: To observe the myocardial protection effects of STV-1Na (a kaurane of
natural origin) on Sprague-Dawley (SD) rats with myocardial infarctions (MI).
Methods: SD rats were randomly assigned to Myocardial infarction group (MI)
(n¼30), sham group (S) (n¼30), MI-Trimetazidine group (MT) (0.03mg/100g,
n¼30), MI-low dose (ML) (0.05mg/100g, n¼30), MI-middle dose (MM) (0.1mg/
100g, n¼30) and MI-high dose (MH) STV-1Na group (0.4mg/100g, n¼30). The MI
model was set up in SD rats by permanent ligation of the left anterior descending
coronary artery (LAD).Sham group suture were through the LAD without ligation.
Before and after MI, in MI group and MI-T group normal saline and Trimetazidine
were given by gavage, and different dose groups of STV-1Na were given by gavage.
The changes of serum cTnI were observed at 8th, 24th, 48th hour after MI. In 1 week,
2 weeks, and 4 weeks after treatment, the area of myocardial infarction were analyzed,
maximal rate of left ventricular pressure (dp/dtmax) and minimum rate of left
ventricular pressure rise (dp/dtmin) were measured to evaluate the effects of STV-1Na.
The statistical signiﬁcance of differences was analyzed using SPSS 13.0 for Windows.
Groups were compared with one-way analysis of variance (ANOVA) test. A value of
P< 0.05 was considered statistically signiﬁcant.
Results: At 8th hour after MI the serum cTnI level of each group was no statistically
signiﬁcant difference (P>0.05). But ML, MM, MH and MT group decreased the
serum cTnI level signiﬁcantly at 24th hour after MI (P<0.01) (MI (42.35.4 ng/ml),
ML (17.04.3 ng/ml), MM (21.33.7 ng/ml), MH (22.26.5 ng/ml), MT
(22.75.3 ng/ml) ). ML group and MM group decreased the serum cTnI level
(P<0.05), and MH group decreased signiﬁcantly the serum cTnI level (P<0.01) at
48th hour after MI (MI (3.70.9 ng/ml), ML (1.30.7 ng/ml), MM (1.30.8 ng/ml),
MH (1.00.4 ng/ml) ). ML group and MM group decreased the myocardial infarction
area (P<0.05), MH group and MT group decreased the myocardial infarction area
signiﬁcantly (P<0.01) (MI (0.3620.027), ML (0.2840.027), MM (0.2680.023),
MH (0.2540.011), MT (0.2480.021) ). In 1 week after MI, MM group, MH group
and MT group increased dp/dtmax (P<0.05). The dp/dtmax were no signiﬁcant
difference (P>0.05) between ML group and MI group. (MI (6702329), ML
(7276221), MM (7782195), MH (7729172), MT (7535265) ). The dp/dtmin in
MT group and ML, MM, MH group were no statistically signiﬁcant difference
(P>0.05) (MI (-5400339), ML (-5690449), MM (-5564204), MH (-5646316),
MT (-5511400) ). In 2 weeks after MI, MT group (8101313) and ML, MM, MH
group increased the dp/dt max signiﬁcantly (P<0.01). (MI (5868412), MT
(8101313), ML (7658392), MM (8499343), MH (7521385) ) ; MT group, ML
group and MM group decreased the dp/dtmin (P<0.05). The dp/dtmin were no dif-
ference between MH group and MI group (P>0.05) (MI (-4750463), MT
(-6514493), ML (-6275623), MM (-7305491), MH (-5676640) ). In 4 weeks
after MI, MT group, ML group, MM group and MH group increased the dp/dt max
signiﬁcantly. (MI (5876200), MT (7629374, P<0.01), ML (7264348, P<0.05),
MM (7743242, P<0.01), MH (7537185, P<0.01) ).MT group, MM group and
MH group decreased the dp/dtmin signiﬁcantly (P<0.05); ML group didn’t no
decreased the dp/dtmin signiﬁcantly (P>0.05) (MI (-4546279), ML (-5528505),
MT (-5883436), MM (-6132533), MH (-5801343) ).
Conclusions: STV-1Na has myocardial protection effects on myocardial infarction
and improves myocardial systolic and diastolic function in SD rats with acute
myocardial infarction. The effects of STV-1Na were as good as the effects of
Trimetazidine.
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Effect of Myocardial Ischemic Postconditioning Protects Reperfusion Injury in
Diabetic and Pharmacological Postconditioning
Zhao Xin, Yu Xue Fan, Zheng Yang
Department of Cardiology, First Hospital of Jilin University, Jilin, China
Objectives: Clinical studies in patients with acute myocardial infarction have
demonstrated that Postconditioning (IPO) was effective in reducing infarct size. We
studied cardioprotection of IPO in diabetic heart existence or no, and how to wake-up
and recovery cardioprotection of IPO in diabetic heart, whether the diabetic heart is
amenable to ischaemic postconditioning is an important unanswered question.
Previous studies have demonstrated that postconditioning signals through the PI3K-
Akt kinase pathway. Other studies have documented impaired PI3K-Akt signalling in
the diabetic myocardium. We hypothesised that due to impaired signaling through the
PI3K-Akt pathway, postconditioning does not protect the diabetic heart.
Methods: Diabetic cardiomyopathy rats was induced by intraperitoneal streptozotocin
(STZ, 30mg/kg) injection.One week following STZ injection, and blood glucose
levels>120 mg/dL were included in the study. high-fat diet rats receiving high-
saturated-fat diet consisting of 35% fat, 35% carbohydrates, and 22% protein for 4
weeks.Hearts were rapidly excised and immediately mounted on Langendorff-perfu-
sion apparatus. Perfusion was maintained at a constant pressure of 75 mmHg.Isolated
hearts were obtained from two groups: healthy controls (n¼10), streptozotocin
(STZ) +HFD-induced diabetes (n¼12). All hearts underwent 25 min ischemia andasic and Translational Medicine C73
